Kairos Pharma, Ltd.(KAPA)
Biotechnology
Oncology Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2024-11-25 | Murali Ramachandran VP of Research and Development | Purchase | +200 | +0.15%133,057 | $1.59 | $318 | View SEC filing | |
| 2024-11-25 | Samuelson Doug Chief Financial Officer | Purchase | +2,500 | +4.29%60,796 | $1.50 | $3,750 | View SEC filing | |
| 2024-11-21 | Yu John S CEO and Chairman | Purchase | +4,000 | +0.07%5,341,837 | $1.44 | $5,760 | View SEC filing |
1-3 of 3